Overview

A Study of Brain Receptor Occupancy in Healthy Subjects

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To measure the occupancy of brain kappa opioid receptors after single oral doses of LY2456302.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Analgesics, Opioid
Aticaprant